Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Debt to Equity 
since 2005

Microsoft Excel

Calculation

Bristol-Myers Squibb Co., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Total debt1 ÷ Total BMS shareholders’ equity1
Dec 31, 2024 3.04 = 49,649 ÷ 16,335
Dec 31, 2023 1.35 = 39,772 ÷ 29,430
Dec 31, 2022 1.27 = 39,320 ÷ 31,061
Dec 31, 2021 1.24 = 44,553 ÷ 35,946
Dec 31, 2020 1.34 = 50,676 ÷ 37,822
Dec 31, 2019 0.91 = 46,733 ÷ 51,598
Dec 31, 2018 0.52 = 7,349 ÷ 14,031
Dec 31, 2017 0.68 = 7,962 ÷ 11,741
Dec 31, 2016 0.41 = 6,708 ÷ 16,177
Dec 31, 2015 0.47 = 6,689 ÷ 14,266
Dec 31, 2014 0.53 = 7,832 ÷ 14,852
Dec 31, 2013 0.55 = 8,340 ÷ 15,154
Dec 31, 2012 0.54 = 7,394 ÷ 13,623
Dec 31, 2011 0.34 = 5,491 ÷ 15,956
Dec 31, 2010 0.35 = 5,445 ÷ 15,713
Dec 31, 2009 0.43 = 6,361 ÷ 14,843
Dec 31, 2008 0.55 = 6,739 ÷ 12,241
Dec 31, 2007 0.59 = 6,272 ÷ 10,562
Dec 31, 2006 0.74 = 7,435 ÷ 9,991
Dec 31, 2005 0.77 = 8,595 ÷ 11,208

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Comparison to Competitors

Bristol-Myers Squibb Co., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Bristol-Myers Squibb Co. AbbVie Inc. Amgen Inc. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Vertex Pharmaceuticals Inc.
Dec 31, 2024 3.04 20.19 10.23 0.32 2.37 1.38 0.51 0.80 0.73 0.09 0.63 0.01
Dec 31, 2023 1.35 5.73 10.37 0.34 2.34 1.09 0.43 0.93 0.81 0.10 0.75 0.02
Dec 31, 2022 1.27 3.67 10.64 0.39 1.52 1.19 0.52 0.67 0.37 0.12 0.78 0.03
Dec 31, 2021 1.24 4.98 4.97 0.49 1.88 1.27 0.46 0.87 0.50 0.14 0.85 0.06
Dec 31, 2020 1.34 6.58 3.51 0.53 2.94 1.73 0.56 1.26 0.63 0.24 0.63 0.07
Dec 31, 2019 0.91 — 3.09 0.72 5.88 1.09 0.47 1.02 0.83 0.06 0.60 0.09
Dec 31, 2018 0.52 — 2.71 0.35 1.30 1.28 0.51 0.94 0.66 0.08 0.69 0.13
Dec 31, 2017 0.68 7.33 1.40 0.40 1.18 1.64 0.57 0.71 0.60 0.11 0.83 0.29
Dec 31, 2016 0.41 7.95 1.16 0.53 0.74 1.39 0.39 0.62 0.71 0.11 0.77 0.71
Dec 31, 2015 0.47 8.03 1.12 0.54 0.55 1.20 0.28 0.59 0.60 0.10 0.59 0.86
Dec 31, 2014 0.53 8.62 1.19 0.15 0.52 0.80 0.27 0.44 0.51 0.18 0.71 0.75
Dec 31, 2013 0.55 3.28 1.45 0.16 0.30 0.58 0.25 0.50 0.48 0.26 0.62 0.36
Dec 31, 2012 0.54 4.66 1.39 0.28 0.37 0.88 0.25 0.39 0.46 0.37 0.46 0.68
Dec 31, 2011 0.34 — 1.13 0.31 0.52 1.13 0.34 0.32 0.47 0.90 0.47 0.58
Dec 31, 2010 0.35 — 0.56 0.21 0.56 0.59 0.30 0.33 0.50 0.31 0.14 1.07
Dec 31, 2009 0.43 — 0.47 0.25 0.70 0.18 0.29 0.30 0.54 0.27 0.14 0.14
Dec 31, 2008 0.55 — 0.50 0.27 1.55 0.31 0.28 0.33 0.30 0.00 0.14 1.20
Dec 31, 2007 0.59 — 0.63 0.41 0.37 0.38 0.22 0.32 0.20 0.43 0.15 0.07
Dec 31, 2006 0.74 — 0.48 0.37 0.34 0.77 0.17 0.39 0.11 0.92 0.19 0.24
Dec 31, 2005 0.77 — 0.19 0.21 0.60 0.10 0.07 0.45 0.27 1.75 0.21 0.75

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Bristol-Myers Squibb Co., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Bristol-Myers Squibb Co. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2024 3.04 1.04
Dec 31, 2023 1.35 0.97
Dec 31, 2022 1.27 0.80
Dec 31, 2021 1.24 0.93
Dec 31, 2020 1.34 1.12
Dec 31, 2019 0.91 1.09
Dec 31, 2018 0.52 0.93
Dec 31, 2017 0.68 0.87
Dec 31, 2016 0.41 0.79
Dec 31, 2015 0.47 0.68
Dec 31, 2014 0.53 0.55
Dec 31, 2013 0.55 0.52
Dec 31, 2012 0.54 0.51
Dec 31, 2011 0.34 0.46
Dec 31, 2010 0.35 0.40
Dec 31, 2009 0.43 0.39
Dec 31, 2008 0.55 0.37
Dec 31, 2007 0.59 0.30
Dec 31, 2006 0.74 0.25
Dec 31, 2005 0.77 0.29

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Bristol-Myers Squibb Co., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Bristol-Myers Squibb Co. Health Care
Dec 31, 2024 3.04 0.87
Dec 31, 2023 1.35 0.82
Dec 31, 2022 1.27 0.73
Dec 31, 2021 1.24 0.79
Dec 31, 2020 1.34 0.92
Dec 31, 2019 0.91 0.92
Dec 31, 2018 0.52 0.86
Dec 31, 2017 0.68 0.81
Dec 31, 2016 0.41 0.76
Dec 31, 2015 0.47 0.69
Dec 31, 2014 0.53 0.52
Dec 31, 2013 0.55 0.49
Dec 31, 2012 0.54 0.51
Dec 31, 2011 0.34 0.45
Dec 31, 2010 0.35 0.42
Dec 31, 2009 0.43 0.41
Dec 31, 2008 0.55 0.41
Dec 31, 2007 0.59 0.36
Dec 31, 2006 0.74 0.33
Dec 31, 2005 0.77 0.30

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).